Objective: Tea contains antioxidant compounds from the polyphenol group known as catechins. The most abundant of catechins is Epigallocatechin3-gallate (EGCG). Epidemiological studies show that tea has a protective effect against cancer, neuronal damage after transient global ischemia and cardiovascular diseases. This study aimed to investigate a possible neuroprotective effect of EGCG in a rat spinal cord injury (SCI) model. Materials and Methods: The study was performed with 35 Albino-Wistar rats. Rats were divided into five groups: daily consumption group (intraperitoneal given ECGC 1.7 mg/kg/day), treatment groups (intraperitoneal given ECGC 5 mg/kg/day and 10 mg/kg/day), saline group and control group for 14 days prior to trauma. All groups, other than the control group, injured with a pressure of 35 g/cm2 and 1-minute compression. These operations were applied to the spinal cord at level T9-T10. In all groups, nerve samples were taken after 28 days and examined biochemically and histopathologically. Results: In our study, daily consumption ECGC group, 5 mg/kg ECGC group and 10 mg/kg ECGC group statistically significant lower level of lipid peroxidation. Especially daily consumption ECGC group and 5 mg/kg ECGC group were positively decreased histological degeneration and oedema. Histological evaluation, white-grey matter sparing, glial scar formation, protoplasmic astrocytes’ number, cavity size, also had better results in these groups. Conclusion: In this study, it has been shown that catechin group antioxidant substances in tea have a protective effect in neuronal damage such as SCI.
Tian ZR, Sharma A, Nozari A, Subramaniam R, Lundstedt T, Sharma HS. Nanowired drug delivery to enhance neuroprotection in spinal cord injury. CNS Neurol Disord Drug Target. 2012;11:86-95.
Menon PK, Muresanu DF, Sharma A, Mössler H, Sharma HS. Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection inspinal cord injury following intoxication of engineered nanoparticles from metals. CNS Neurol Disord Drug Target. 2012;11:40-9.
Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol. 2011;70:194-206.
Silva NA, Sousa N, Reis RL, Salgado AJ. From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol. 2014;114:25-57.
Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41:1819-28.
Cheeseman Kh, Slater TF. An introduction to free radical biochemistry. British Med Bulletin. 1993;149:481-93.
Hall ED, Braughler M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na-K ATPase activity. J Neurosurg. 1982;57:247-53.
Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr. 2003;133:3275S-84S.
Yilmaz Y. Novel uses of catechins in foods. Trends in Food Sci Technol. 2006;17:64-71.
Sutherland BA, Rahman RMA, Appleton I. Mechanisms of action of gren tea catechins, with a focus on ischemiainduced neurodegeneration. J Nutr Biochem. 2006;17:291-306.
Zhang S, Liu Y, Zhao Z, Xue Y. Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia. Neurol Res. 2010;32:963-70.
Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 2004;25:177-95.
Persengiev S, Kanchev L, Vezenkova G. Circadian patterns of melatonin, corticosterone, and progesterone in male rats subjected to chronic stress: Effect of constant illumination. JPineal Res. 1991;11:57-62.
Zhang YL, Zhang PB, Qiu SD, Liu Y, Tian YF, Wang Y. Effects of ketamine-midazolam anesthesia on the expression of NMDA and AMPA receptor subunit in the peri-infarction of rat brain. Chin Med J. 2006;119:1555-62.
Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol. 1973;10:38-43.
David S, Greenhalgh AD, López-Vales R. Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury. Cell Tissue Res. 2012;349:249e267.
Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma. 2006;23:264e280.
Cadotte DW, Fehlings MG. Spinal cord injury: a systematic review of current treatment options. Clin Orthop Rela T Res. 2011;469:732e741.
Khalatbary AR, Tiraihi T, Boroujeni MB, Ahmadvand H, Tavafi M, Tamjidipoor A. Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats. Brain Res. 2010;1306:168-75.
Renno WM, Al-Khaledi G, Mousa A, Karam SM, Abul H, Asfar S. (-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and chronically injured spinal cord of adult rats. Neuropharmacology. 2014;77:100-19.
Khalatbary AR, Ahmadvand H. Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat. Iran Biomed J. 2011;15:31-7.
Xuczaj W, Skrzydlewska E. Antioxidative properties of black tea. Prev Med. 2005;40: 910-8.